Taipei mayoral election campaigns have been clouded by issues concerning Taiwan’s COVID-19 response and vaccine procurement over the past two years.
As Democratic Progressive Party (DPP) Taipei mayoral candidate Chen Shih-chung (陳時中) was head of the Central Epidemic Command Center (CECC) for more than 900 days during the COVID-19 pandemic, his political opponents have been attacking him for what they called “poor COVID-19 responses.”
The Chinese Nationalist Party’s (KMT) Legislator and Taipei mayoral candidate Chiang Wan-an (蔣萬安) and independent Taipei mayoral candidate Vivian Huang (黃珊珊), a former Taipei deputy mayor, have aggressively and negatively campaigned against Chen.
Since Chen announced his bid for mayor in July, he has been called a “runaway CECC head,” criticized for cutting quarantine time and causing local COVID-19 outbreaks, branded incapable of securing enough vaccines last year, and accused of blocking vaccine purchases, concealing vaccine prices and wasting taxpayer money by disposing of expired vaccines.
Huang said that Chen was “murdering for money,” as she claimed the government had blocked the purchase of imported vaccines to profit from Taiwan’s homegrown Medigen COVID-19 vaccine.
Chiang also said Chen showed “disregard for human lives” and “had no empathy for the victims’ families,” while the KMT legislative caucus last week filed a complaint against him for alleged dereliction of duty in purchasing COVID-19 vaccines.
When the local outbreak of the Omicron variant of SARS-CoV-2 began in April, the KMT consistently called for Chen to step down as CECC head due to his “poor COVID-19 response,” but it criticized him for “running away” when he resigned in July after the infections stabilized. Daily local caseloads dropped to about 20,000 from the peak of about 90,000, while antiviral drug prescriptions and COVID-19 hospital bed vacancy rates were high.
The KMT legislative caucus in July 2020 urged the government to allocate more funding for domestic COVID-19 vaccine development and ease clinical trial requirements due to fears that the nation would not gain access to vaccine supplies as fast as other countries. After the government purchased vaccines, the KMT later labeled the AstraZeneca vaccine “unwanted” and dangerous, saying it could cause blood clots. It called receivers of the Medigen vaccine “lab rats,” demanded a greater supply of the Pfizer-BioNTech vaccine and questioned whether vaccines had been purchased at inflated prices.
The KMT’s demands — buying vaccines before other countries at low cost, providing vaccine brand variety, revealing non-disclosure agreements, not wasting taxpayers’ money by purchasing too many doses, while also funding research for domestically made vaccines — are basically impossible.
In January last year, Israel was ahead of many bigger countries in COVID-19 vaccination rates. It paid a premium to get early Pfizer-BioNTech vaccines, agreeing to provide the vaccine company with efficacy data among those vaccinated. Although its contract with Pfizer was made public shortly after it was signed, the specifics around the cost were redacted.
Pfizer-BioNTech had stated that it uses “a tiered pricing formula based on volume and delivery dates,” and the CECC has clarified that a non-disclosure agreement was signed with the vaccine manufacturers, yet the KMT continues to obscure the facts.
While many countries have reported destroying millions of expired COVID-19 vaccines, including the US, which discarded 82.1 million doses from December 2020 to mid-May, the KMT continues to attack Chen for the disposal of Taiwan’s expired vaccines.
Negative campaigning focused on previous COVID-19 policies does not improve the well-being of Taipei residents. Debates on policies for better municipal governance would be more constructive.
Former US president Jimmy Carter’s legacy regarding Taiwan is a complex tapestry woven with decisions that, while controversial, were instrumental in shaping the nation’s path and its enduring relationship with the US. As the world reflects on Carter’s life and his recent passing at the age of 100, his presidency marked a transformative era in Taiwan-US-China relations, particularly through the landmark decision in 1978 to formally recognize the People’s Republic of China (PRC) as the sole legal government of China, effectively derecognizing the Republic of China (ROC) based in Taiwan. That decision continues to influence geopolitical dynamics and Taiwan’s unique
Having enjoyed contributing regular essays to the Liberty Times and Taipei Times now for several years, I feel it is time to pull back. As some of my readers know, I have enjoyed a decades-long relationship with Taiwan. My most recent visit was just a few months ago, when I was invited to deliver a keynote speech at a major conference in Taipei. Unfortunately, my trip intersected with Double Ten celebrations, so I missed the opportunity to call on friends in government, as well as colleagues in the new AIT building, that replaced the old Xin-yi Road complex. I have
On New Year’s Day, it is customary to reflect on what the coming year might bring and how the past has brought about the current juncture. Just as Taiwan is preparing itself for what US president-elect Donald Trump’s second term would mean for its economy, national security and the cross-strait “status quo” this year, the passing of former US president Jimmy Carter on Monday at the age of 100 brought back painful memories of his 1978 decision to stop recognizing the Republic of China as the seat of China in favor of the People’s Republic of China. It is an
After forcing through a slew of controversial amendments, the opposition Chinese Nationalist Party (KMT) and Taiwan People’s Party (TPP) on Tuesday last week rejected all seven Constiutional Court candidates nominated by President William Lai (賴清德), an event that triggered public concerns that it could lead to an unprecedented constitutional crisis and jeopardize Taiwan’s democracy. The opposition parties on Dec. 20 forced through three controversial amendments to the Public Officials Election and Recall Act (公職人員選舉罷免法), the Act Governing the Allocation of Government Revenues and Expenditures (財政收支劃分法) and the Constitutional Court Procedure Act (憲法訴訟法). The amendment to tighten the recall process has been